RudaCure Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

RudaCure General Information

Description

Developer of an eye medicine designed for dry eye disease. The company offers a product in development that resolves the eye dryness problem, enabling patients with a non-opioid treatment for chronic pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 302 of the BRC Research Institute
  • Songdo Mi-rae-ro 9, Yeonsu
  • Incheon, 21988
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Building 302 of the BRC Research Institute
  • Songdo Mi-rae-ro 9, Yeonsu
  • Incheon, 21988
  • South Korea
+82

RudaCure Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RudaCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Apr-2024 Completed Pre-Clinical Trials
6. Accelerator/Incubator Completed Pre-Clinical Trials
5. Accelerator/Incubator 30-Sep-2023 Completed Pre-Clinical Trials
4. Later Stage VC (Series A) 30-May-2023 Completed Pre-Clinical Trials
3. Accelerator/Incubator 18-Oct-2022 Completed Startup
2. Accelerator/Incubator 16-Sep-2021 Completed Startup
1. Seed Round 13-Apr-2021 Completed Startup
To view RudaCure’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RudaCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RudaCure Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
J Curve Investment Venture Capital Minority
Tech Incubator Program for Startups Accelerator/Incubator
CKD Venture Capital Corporate Venture Capital Minority
Darae Venture Capital Minority
BiiG WAVE Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

RudaCure FAQs

  • When was RudaCure founded?

    RudaCure was founded in 2018.

  • Where is RudaCure headquartered?

    RudaCure is headquartered in Incheon, South Korea.

  • What is the size of RudaCure?

    RudaCure has 13 total employees.

  • What industry is RudaCure in?

    RudaCure’s primary industry is Pharmaceuticals.

  • Is RudaCure a private or public company?

    RudaCure is a Private company.

  • What is RudaCure’s current revenue?

    The current revenue for RudaCure is .

  • How much funding has RudaCure raised over time?

    RudaCure has raised $300K.

  • Who are RudaCure’s investors?

    J Curve Investment, Tech Incubator Program for Startups, CKD Venture Capital, Darae, and BiiG WAVE are 5 of 9 investors who have invested in RudaCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »